<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>niosomal drug delivery systems &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/niosomal-drug-delivery-systems/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 05 Nov 2025 18:51:14 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>niosomal drug delivery systems &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Boosting Cisplatin Chemo with Niosomal Propolis, Chrysin</title>
		<link>https://bioengineer.org/boosting-cisplatin-chemo-with-niosomal-propolis-chrysin/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 05 Nov 2025 18:51:07 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cisplatin chemotherapy enhancement]]></category>
		<category><![CDATA[natural compounds in chemotherapy]]></category>
		<category><![CDATA[niosomal drug delivery systems]]></category>
		<category><![CDATA[overcoming cancer drug resistance]]></category>
		<category><![CDATA[reducing cisplatin toxicity]]></category>
		<guid isPermaLink="false">https://bioengineer.org/boosting-cisplatin-chemo-with-niosomal-propolis-chrysin/</guid>

					<description><![CDATA[In the continuous battle against cancer, one of the cornerstone chemotherapeutic agents, cisplatin, has seen widespread use due to its potent cytotoxic effects against various malignancies. Despite its efficacy, the drug’s clinical utility is often hampered by significant toxicity and the eventual development of resistance by tumor cells. Recently, a groundbreaking study published in Medical [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292093</post-id>	</item>
	</channel>
</rss>
